Does tumour effraction during robotic partial nephrectomy have any impact on recurrence?
- 40 Downloads
To evaluate the impact of accidental surgical incision into the tumour (ASIT) on oncological outcomes in patients undergoing RPN for a malignant tumour.
Materials and methods
A retrospective review of our prospectively maintained database was performed to identify all patients who underwent RPN for a localized RCC between June 2010 and July 2016. We stratified our cohort into two groups according to the presence of an ASIT. Perioperative data were compared between the two groups. Logistic regression analyses were used to assess the variables associated with ASIT. Recurrence-free survival was estimated using the Kaplan–Meier method and compared between groups with the log-rank test.
A total of 234 patients were identified. 32 (14%) ASIT were observed. Patients’ characteristics were similar in the two groups. Most of intraoperative outcomes were comparable between the two groups, but patients in the ASIT group had greater EBL (475 vs. 300 mL; p = 0.01). In multivariate analysis, tumour size (p = 0.02), RENAL score (p = 0.02), EBL (p = 0.05) and low surgeon experience (p = 0.03) were all predictive factors of ASIT. 15 (6%) of recurrences were observed over a median follow-up of 36 months. There was no difference in recurrence-free survival between the two groups (p = 0.57).
In our experience, accidental surgical incision into the tumour during RPN was a common event that did not appear to compromise oncological outcome.
KeywordsPartial nephrectomy Robotic surgical procedures Recurrence Complications Survival
Compliance with ethical standards
Conflict of interest
The author declares that there is no competing interest.
- 1.Campbell S, Uzzo RG, Allaf ME et al (2017) Renal mass and localized renal cancer: AUA guideline. J Urol [Internet] 198:520–529Google Scholar
- 23.Bhindi B, Lohse CM, Mason RJ et al (2017) Are we using the best tumor size cut-points for renal cell carcinoma staging? Urology 109:121–126Google Scholar
- 28.Rolevich A, Minich A, Nabebina T et al (2016) Surgeon has a major impact on long-term recurrence risk in patients with non-muscle invasive bladder cancer. Cent Eur J Urol 69(2):170–177Google Scholar